Pinsent Masons continues its expansion in Amsterdam with the hiring of the Taylor Wessing team

Pinsent Masons has recruited a life sciences intellectual property team led by a Taylor Wessing partner to its Amsterdam office, furthering the company’s expansion into a key practice area in the heart of Europe.

Judith Krens, Partner, joins Pinsents after five years at Taylor Wessing, where she led the life sciences practice in the Netherlands.

Previously, she practiced at European intellectual property boutique Hoyng Rokh Monegier, transitioning to consulting, and spent three years as in-house counsel at Cognizant Technology Solutions, a US-based multinational technology consulting and services company. .

His career also includes associate stints at Debevoise & Plimpton, legacy firm Lovells (now Hogan Lovells) and Dutch firm Stibbe.

Krens joins Pinsents along with senior partner Marthe Riewald and partner Maud de Haas, both of whom worked with her at Taylor Wessing.

Educated in the Netherlands and the United States, and with a background in chemistry as well as law, Krens brings experience in cross-border patent litigation and drug regulation, according to a statement from Pinsent Masons.

Pinsents opened in Amsterdam a year ago with the aim of creating an intellectual property center for life sciences in the city, which houses the European Medicines Agency, the drug regulatory body of the European Union.

Krens becomes the fifth partner in the Amsterdam office and the third in Life Sciences IP, joining András Kupecz and Machteld Hiemstra, who both arrived last year after long stints at Simmons & Simmons.

With the arrival of Krens and his team, the firm will have 17 professionals.

“Judith is a fantastic addition to our European life sciences team,” Clare Tunstall, global head of intellectual property and life sciences for Pinsent Masons, said in a statement announcing the move.

Wouter Seinen, head of the Amsterdam office, told International that he was delighted to have Krens join the firm because “she is a very strong life science patent lawyer and a great personality.

“The Netherlands is of great strategic importance to the pharmaceutical and wider life sciences industry, and with the arrival of Judith and her team, we have been able to set up one of strongest pharmaceutical IP practices in the market in 12 months,” said Seinen. “It’s something to be proud of.”

In addition to her practice, Krens is co-founder and board member of Female Intellectual Property Experts, a women’s network for female intellectual property professionals.

Pinsent Masons has women leading several key offices, including London, Paris, Munich and Sydney, and global practice areas including energy, healthcare, risk advisory services, employment and compensation, and life sciences intellectual property. Women also hold four of the nine seats on the company’s board of directors.

“I’m thrilled to see so many women in leadership positions” at Pinsent Masons, Krens told International. “I am extremely proud to join the firm and hope to be able to bring both my experience as a life scientist and as a female leader and contribute to future growth.”

Taylor Wessing’s head of patents and innovation, Wim Maas, said in a statement: Judith leaves with our best wishes for the future.

More Stories
Ted Baker sales jump 35% on resilient demand in Omicron-hit quarter